Letter to the Editor Regarding “Acute Hemorrhage After Intracerebral Biopsy in COVID-19 Patients: A Report of 3 Cases”

Munakomi, Sunil; Bharati, Kanchan

doi:10.1016/j.wneu.2020.06.128

World Neurosurgery

2020

DOI: 10.1016/j.wneu.2020.06.128

|View full text |Cite

Letter to the Editor Regarding “Acute Hemorrhage After Intracerebral Biopsy in COVID-19 Patients: A Report of 3 Cases”

Sunil Munakomi

Kanchan Bharati

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

2021

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(10 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We appreciate the interest of, and valuable suggestions from, Munakomi et al. 1 regarding our recently reported study “Acute Hemorrhage After Intracerebral Biopsy in COVID-19 Patients: A Report of 3 Cases.”…”

mentioning

confidence: 90%

“…In Response to the Letter to the Editor Regarding "Acute Hemorrhage After Intra-cerebral Biopsy in Patients: A Report of 3 Cases" W e appreciate the interest of, and valuable suggestions from, Munakomi et al 1 regarding our recently reported study "Acute Hemorrhage After Intracerebral Biopsy in COVID-19 Patients: A Report of 3 Cases. "…”

mentioning

confidence: 98%

“…In their letter, Munakomi et al 1 rightly emphasized the necessity for preoperative screening of patients with coronavirus disease 2019 (COVID-19) to identify those patients prone to hemorrhagic complications after neurosurgical interventions. They discussed the 3 stages of NeuroCOVID, described by Fotuhi et al 2 NeuroCOVID stage I, in which the binding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is limited to the angiotensin-converting enzyme II receptors in the nasal and gustatory cells, can lead to impairment of smell or taste, without a significant cytokine storm.…”

mentioning

confidence: 99%

“…Real-time reverse-transcription polymerase chain reaction tests showed the presence of SARS-CoV-2 in 9 of the 11 cerebral samples. 4 Munakomi et al 1 proposed the assessment of anosmia and ageusia and the examination of the viral load of SARS-CoV-2 in the cerebrospinal fluid (CSF) to screen for high-risk patients. However, we believe that careful interpretation is needed when assessing these data.…”

mentioning

confidence: 99%

“…It is crucial to realize that patients with COVID-19 can present with a variety of immune-mediated neurological symptoms but that other underlying etiologies could still be present and have resulted in their neurological conditions. 2 Second, SARS-CoV-2 CSF analysis has been proposed by Munakomi et al 1 Several cases of SARS-CoV-2etriggered immune-mediated encephalopathy or meningitis have been reported. Three cases were found with a positive PCR test from a SARS-CoV-2 CSF analysis.…”

mentioning

confidence: 99%

See 4 more Smart Citations

In Response to the Letter to the Editor Regarding “Acute Hemorrhage After Intra-cerebral Biopsy in COVID-19 Patients: A Report of 3 Cases”

2020

View full text Add to dashboard Cite

mentioning

confidence: 90%

mentioning

confidence: 98%

mentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 3 more Smart Citations

In Response to the Letter to the Editor Regarding “Acute Hemorrhage After Intra-cerebral Biopsy in COVID-19 Patients: A Report of 3 Cases”

2020

View full text Add to dashboard Cite

Cerebrovascular Complications of Covid-19

Lychko

Burtyka

2021

EUMJ

View full text Add to dashboard Cite

The systematic online search of articles utilizing the search terms ”Coronavirus, SARS-COV-2 and Neurological complications”, published between January 2019 and September 2021, was performed. Neurological manifestations are prevalent during infection with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There is a clear association between cerebrovascular disease and coronavirus disease 2019 (COVID-19). But today, whether this association is causal or incidental is still unknown. This systemic review presents the possible pathophysiological mechanisms linking COVID-19 and cerebrovascular disease, describes the most often neurological complications and their prognosis, discusses several clinical and laboratory characteristics. A systematic literature search was conducted, and relevant information was abstracted. Angiotensin-converting enzyme-2 receptor dysregulation, uncontrollable immune storm with inflammation, coagulopathy, complications due to critical illness and prolonged hospitalization can all contribute as potential etiological and pathogenic mechanisms leading to diverse cerebrovascular clinical manifestations. Acute ischemic stroke, intracerebral haemorrhage, and cerebral venous sinus thrombosis have been described in case reports and cohorts of COVID-19 patients, with a prevalence ranging between 0.5 % and 5.0 %. SARS-CoV-2-positive stroke patients have higher mortality rates, worse functional outcomes at discharge and longer duration of hospitalization as compared with SARS-CoV-2-negative stroke patients. Understanding of the specific demographic, clinical, laboratory and radiological characteristics may be used as ‘red flags’ in recognizing COVID-19-related acute neurological complications.

show abstract

Neurological Complications of COVID-19: Underlying Mechanisms and Management

Shehata

Lord

Grudzinski

et al. 2021

IJMS

View full text Add to dashboard Cite

COVID-19 is a severe respiratory disease caused by the newly identified human coronavirus (HCoV) Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The virus was discovered in December 2019, and in March 2020, the disease was declared a global pandemic by the World Health Organization (WHO) due to a high number of cases. Although SARS-CoV-2 primarily affects the respiratory system, several studies have reported neurological complications in COVID-19 patients. Headache, dizziness, loss of taste and smell, encephalitis, encephalopathy, and cerebrovascular diseases are the most common neurological complications that are associated with COVID-19. In addition, seizures, neuromuscular junctions’ disorders, and Guillain–Barré syndrome were reported as complications of COVID-19, as well as neurodegenerative and demyelinating disorders. However, the management of these conditions remains a challenge. In this review, we discuss the prevalence, pathogenesis, and mechanisms of these neurological sequelae that are secondary to SARS-CoV-2 infection. We aim to update neurologists and healthcare workers on the possible neurological complications associated with COVID-19 and the management of these disease conditions.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Letter to the Editor Regarding “Acute Hemorrhage After Intracerebral Biopsy in COVID-19 Patients: A Report of 3 Cases”

Cited by 3 publications

References 3 publications

In Response to the Letter to the Editor Regarding “Acute Hemorrhage After Intra-cerebral Biopsy in COVID-19 Patients: A Report of 3 Cases”

In Response to the Letter to the Editor Regarding “Acute Hemorrhage After Intra-cerebral Biopsy in COVID-19 Patients: A Report of 3 Cases”

Cerebrovascular Complications of Covid-19

Neurological Complications of COVID-19: Underlying Mechanisms and Management

Contact Info

Product

Resources

About